PRINCETON, NJ – Feb. 01, 2018 – Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has acquired BaseCase, a data visualization software-as-a-service (SaaS) company with offices in Berlin and New York. BaseCase, which will join Certara’s Strategic Consulting Services division, has extensive Health Economics and Outcomes Research (HEOR) expertise and is actively working in the area of market access. As a key element in Certara’s data science portfolio, BaseCase technology will soon be leveraged across the company’s industry-leading pharmacometrics, mechanistic modeling, and regulatory science platforms.
“We are delighted that BaseCase is joining Certara and we are looking forward to expanding the applications for its user-friendly, mobile communications technology. BaseCase simplifies communication of complex data and models,” said Thomas Kerbusch, PhD, President of Certara Strategic Consulting Services. “BaseCase’s interactive platform will enable pharmaceutical and medical technology companies to visualize model results and large, real-world datasets to make sound decisions quickly, within controlled communication cascades,” added Dr. Kerbusch.
“The BaseCase team is excited to join Certara and take adoption of our visualization and communications platform to the next level. We are confident that we are a great match. Both companies have comparable cultures – entrepreneurial, dynamic, diverse, and quality driven – and possess a similar mix of scientific and software engineering staff. With the growing acceptance of modeling and simulation in life sciences, comes the need to simplify complex data science concepts and results. Certara is the perfect home for BaseCase,” said BaseCase CEO Gijs Hubben, PhD.
“Certara’s extensive software development capability and deep expertise in model-informed drug development will enable us to further accelerate BaseCase’s evolution and growth in this expanding market space”, said BaseCase CTO, Diarmuid Glynn. “We have already identified several expansion projects that will result from the merger.”